Taiwan-based biotechnology firm SL Bio Ltd. has filed a Form F-4 with the U.S. Securities and Exchange Commission to advance its merger with Horizon Space Acquisition II Corp. (NASDAQ: HSPT), a deal ...
TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and ...
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Horizon Space Acquisition II Corp. (HSPT), a publicly traded special purpose acquisition company, and SL Bio Ltd. ("SL Bio"), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results